From: Surgery with versus without preoperative concurrent chemoradiotherapy for mid/low rectal cancer: an interim analysis of a prospective, randomized trial
Group
3-year rate (%)
Local recurrence (cases [%])
Distant metastasis (cases [%])
DFS
OS
TME
85.7
90.7
4 (4.3)
12 (12.8)
CCRT + TME
87.9
92.3
4 (4.4)
9 (10.0)
P
0.766
0.855
0.776
0.834